Bradley Partridge
Bradley Partridge
Verified email at
Cited by
Cited by
Smart drugs “as common as coffee”: media hype about neuroenhancement
BJ Partridge, SK Bell, JC Lucke, S Yeates, WD Hall
PLoS one 6 (11), e28416, 2011
Addiction: Current criticism of the brain disease paradigm
R Hammer, M Dingel, J Ostergren, B Partridge, J McCormick, BA Koenig
AJOB neuroscience 4 (3), 27-32, 2013
Deflating the neuroenhancement bubble
JC Lucke, S Bell, B Partridge, WD Hall
AJOB neuroscience 2 (4), 38-43, 2011
Australian university students’ coping strategies and use of pharmaceutical stimulants as cognitive enhancers
C Jensen, C Forlini, B Partridge, W Hall
Frontiers in psychology 7, 277, 2016
Verbal abuse and physical assault in the emergency department: Rates of violence, perceptions of safety, and attitudes towards security
B Partridge, J Affleck
Australasian Emergency Nursing Journal 20 (3), 139-145, 2017
Why Don’t Smokers Want Help to Quit? A Qualitative Study of Smokers’ Attitudes towards Assisted vs. Unassisted Quitting
K Morphett, B Partridge, C Gartner, A Carter, W Hall
International Journal of Environmental Research and Public Health 12 (6 …, 2015
How is acceptance of the brain disease model of addiction related to Australians’ attitudes towards addicted individuals and treatments for addiction?
C Meurk, A Carter, B Partridge, J Lucke, W Hall
BMC psychiatry 14 (1), 1-10, 2014
A ustralian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety
B Partridge, S Bell, J Lucke, W Hall
Drug and alcohol review 32 (3), 295-302, 2013
Australian university students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance
S Bell, B Partridge, J Lucke, W Hall
Neuroethics 6, 197-205, 2013
Ethical concerns in the community about technologies to extend human life span
B Partridge, M Underwood, J Lucke, H Bartlett, W Hall
The American Journal of Bioethics 9 (12), 68-76, 2009
Researchers’ perspectives on scientific and ethical issues with transcranial direct current stimulation: An international survey
K Riggall, C Forlini, A Carter, W Hall, M Weier, B Partridge, M Meinzer
Scientific reports 5 (1), 10618, 2015
Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD
B Partridge, J Lucke, W Hall
BMC psychiatry 14 (1), 1-9, 2014
Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use
J Lucke, C Jensen, M Dunn, G Chan, C Forlini, S Kaye, B Partridge, ...
BMC Public Health 18 (1), 1-7, 2018
Dazed and confused: sports medicine, conflicts of interest, and concussion management
B Partridge
Journal of bioethical inquiry 11, 65-74, 2014
Academic Doping or Viagra for the Brain
JC Lucke, SK Bell, BJ Partridge, WD Hall
EMBO reports 12 (3), 197-201, 2011
A comparison of attitudes toward cognitive enhancement and legalized doping in sport in a community sample of Australian adults
B Partridge, J Lucke, W Hall
AJOB Primary Research 3 (4), 81-86, 2012
Ethical, social, and personal implications of extended human lifespan identified by members of the public
B Partridge, J Lucke, H Bartlett, W Hall
Rejuvenation research 12 (5), 351-357, 2009
Towards a smart population: A public health framework for cognitive enhancement
J Lucke, B Partridge
Neuroethics 6, 419-427, 2013
Concussion in sport: Conceptual and ethical issues
MJ McNamee, B Partridge, L Anderson
Kinesiology Review 4 (2), 190-202, 2015
Public attitudes in A ustralia towards the claim that addiction is a (brain) disease
C Meurk, B Partridge, A Carter, W Hall, K Morphett, J Lucke
Drug and alcohol review 33 (3), 272-279, 2014
The system can't perform the operation now. Try again later.
Articles 1–20